Researchers have developed an innovative drug screening platform designed to identify compounds that precisely target the primary cause of numerous…
Read More
Groundbreaking Drug Screening Platform Developed to Combat Neurological and Psychiatric Diseases by Targeting Protein Expression Imbalances
A pioneering drug screening platform has been successfully developed by researchers, designed to identify compounds that directly address the fundamental…
Read More
Otsuka Pharmaceutical to Acquire Transcend Therapeutics for Up to $1.225 Billion to Bolster Psychiatric and Neurological Pipeline
TOKYO, JAPAN & BOSTON, USA – March 30, 2026 – Otsuka Pharmaceutical Co., Ltd. announced today that its subsidiary, Otsuka…
Read MoreYOU MAY HAVE MISSED
